Literature DB >> 2688212

Challenges for receptor theory as a tool for drug and drug receptor classification.

T P Kenakin.   

Abstract

Increased understanding in the field of receptor pharmacology, born of the sophisticated techniques now available to us, has confounded rather than simplified the problem of receptor classification. The International Union of Pharmacology (IUPHAR) is currently sponsoring a Receptor Nomenclature Committee whose aims are to recommend a rational system of classification, a formidable task given the complexity and volume of data in the literature (agonist/antagonist potencies, coupling mechanisms, primary structures, etc.) that will need to be incorporated. The Committee's chairman, Terry Kenakin, outlines here the limitations of classical receptor theory for drug receptor classification and suggests that any functional classification system must take into account not only affinity and intrinsic efficacy but also, at the very least, parameters relating to the transducing properties of receptors. If this is not done, then receptor classification data obtained from studies with agonists and antagonists may be different and lead to confusion.

Mesh:

Substances:

Year:  1989        PMID: 2688212     DOI: 10.1016/0165-6147(89)90102-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  11 in total

Review 1.  Ligand-gated ion channel currents in a nonstationary lyotropic model.

Authors:  Leif Matsson; Virulh Sa-yakanit; Santipong Boribarn
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

2.  Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists.

Authors:  I van der Ploeg; S Ahlberg; F E Parkinson; R A Olsson; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

Review 3.  The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists.

Authors:  D Jack
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

Review 4.  Drugs and receptors. An overview of the current state of knowledge.

Authors:  T Kenakin
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

5.  Lyotropic ion channel current model compared with ising model.

Authors:  Leif Matsson; Virulh Sa-Yakanit; Santipong Boribarn
Journal:  J Biol Phys       Date:  2005-12       Impact factor: 1.365

6.  Desensitization and functional antagonism by beta-adrenoceptor and muscarinic receptor agonists, respectively: a comparison with receptor alkylation for calculation of apparent agonist affinity.

Authors:  R M Eglen; W W Montgomery; R L Whiting
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

7.  Pharmacological estimation of agonist affinity: detection of errors that may be caused by the operation of receptor isomerisation or ternary complex mechanisms.

Authors:  P Leff; D Harper; I A Dainty; I G Dougall
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

8.  Biphasic dose-response curves to arecoline in rat atria-mediation by a single promiscuous receptor or two receptor subtypes?

Authors:  T P Kenakin; C Boselli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

9.  Characterization of muscarinic receptors mediating relaxation and contraction in the rat iris dilator muscle.

Authors:  Y Masuda; N S Yamahara; M Tanaka; S Ryang; T Kawai; Y Imaizumi; M Watanabe
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

10.  Pertussis toxin-sensitive muscarinic relaxation in the rat iris dilator muscle.

Authors:  N S Yamahara; M Tanaka; Y Imaizumi; M Watanabe
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.